18-657352-T-A

Variant summary

Our verdict is Likely benign. The variant received -2 ACMG points: 2P and 4B. PM2BP4_Strong

The ENST00000701410.1(TYMSOS):​n.245A>T variant causes a non coding transcript exon change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: not found (cov: 31)
Exomes 𝑓: 0.0 ( 0 hom. )
Failed GnomAD Quality Control

Consequence

TYMSOS
ENST00000701410.1 non_coding_transcript_exon

Scores

3

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.883

Publications

30 publications found
Variant links:
Genes affected
TYMSOS (HGNC:29553): (TYMS opposite strand RNA)
TYMS (HGNC:12441): (thymidylate synthetase) Thymidylate synthase catalyzes the methylation of deoxyuridylate to deoxythymidylate using, 10-methylenetetrahydrofolate (methylene-THF) as a cofactor. This function maintains the dTMP (thymidine-5-prime monophosphate) pool critical for DNA replication and repair. The enzyme has been of interest as a target for cancer chemotherapeutic agents. It is considered to be the primary site of action for 5-fluorouracil, 5-fluoro-2-prime-deoxyuridine, and some folate analogs. Expression of this gene and that of a naturally occurring antisense transcript, mitochondrial enolase superfamily member 1 (GeneID:55556), vary inversely when cell-growth progresses from late-log to plateau phase. Polymorphisms in this gene may be associated with etiology of neoplasia, including breast cancer, and response to chemotherapy. [provided by RefSeq, Aug 2017]

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript ENST00000701410.1, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -2 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.77).

Variant Effect in Transcripts

ACMG analysis was done for transcript: ENST00000701410.1. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
TYMSOS
NR_171001.1
n.450+490A>T
intron
N/A

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
TYMSOS
ENST00000323813.6
TSL:1
n.511+490A>T
intron
N/A
TYMSOS
ENST00000701410.1
n.245A>T
non_coding_transcript_exon
Exon 1 of 2
TYMSOS
ENST00000585033.1
TSL:2
n.428+490A>T
intron
N/A

Frequencies

GnomAD3 genomes
Cov.:
31
GnomAD4 exome
Data not reliable, filtered out with message: AC0
AF:
0.00
AC:
0
AN:
21448
Hom.:
0
AF XY:
0.00
AC XY:
0
AN XY:
10876
African (AFR)
AF:
0.00
AC:
0
AN:
776
American (AMR)
AF:
0.00
AC:
0
AN:
552
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
916
East Asian (EAS)
AF:
0.00
AC:
0
AN:
1004
South Asian (SAS)
AF:
0.00
AC:
0
AN:
218
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
1752
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
120
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
14604
Other (OTH)
AF:
0.00
AC:
0
AN:
1506
GnomAD4 genome
Cov.:
31

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.77
CADD
Benign
7.6
DANN
Benign
0.63
PhyloP100
0.88
PromoterAI
-0.011
Neutral
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
0.97

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs2853741;
hg19: chr18-657352;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.